Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sonnet Biotherapeutics Holdings Inc SONN

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company. The Company's technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The Company designed the FHAB construct to improve drug accumulation in cancer tumors, as... see more

NDAQ:SONN - Post Discussion

Sonnet Biotherapeutics Holdings Inc > SONN ..... Sorry Folks.... Can't please everyone ; )
View:
Post by Iseneschal on Oct 31, 2022 11:17am

SONN ..... Sorry Folks.... Can't please everyone ; )

https://invst.ly/zdkce
Comment by Chefboy69 on Oct 31, 2022 11:28am
WEED  called it bro...lol
Comment by Iseneschal on Oct 31, 2022 12:31pm
You're turning this into a "pissing match".......LMFAO WEED.....LoL Canopy Growth loses $2.08-billion in fiscal Q1 2022-08-05 06:22 ET - News Release   Mr. David Klein reports CANOPY GROWTH CORPORATION REPORTS FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS Canopy Growth Corp. has released its financial results for the first quarter ended June 30, 2022. Highlights ...more